0001209191-22-003395.txt : 20220114
0001209191-22-003395.hdr.sgml : 20220114
20220114203016
ACCESSION NUMBER: 0001209191-22-003395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200301
FILED AS OF DATE: 20220114
DATE AS OF CHANGE: 20220114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ONEILL ALISON
CENTRAL INDEX KEY: 0001283882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38459
FILM NUMBER: 22533295
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Surface Oncology, Inc.
CENTRAL INDEX KEY: 0001718108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-714-4096
MAIL ADDRESS:
STREET 1: 50 HAMPSHIRE STREET, 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-01
0
0001718108
Surface Oncology, Inc.
SURF
0001283882
ONEILL ALISON
C/O SURFACE ONCOLOGY, INC.
50 HAMPSHIRE STREET, 8TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Common Stock
2020-03-01
4
A
0
45000
0.00
A
45000
D
Common Stock
2021-07-21
4
S
0
14809
6.10
D
30191
D
The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in full on the date 18 months after January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such date.
Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.
/s/ Jessica Fees, as Attorney-in-Fact
2022-01-14